However, we could not demonstrate co-immunoprecipitation of endogenous BRAF with RAF1, or transiently transfected MYC and FLAG tagged RAF1 in PLX4032-treated melanoma cells under conditions in which RAF1 was activated by the drug. This evidence concerns the gene RAF1 and melanoma.